SSDV Congress
November 9–11, 2022
Kursaal Conference Center Bern

Speakers

Vincenzo Bettoli, Andreas Wollenberg, Alexander Stratigos, Luca Borradori, Giuseppe Argenziano, Britta Maurer, Michel Gilliet, and many more!

Join the SSDV Congress in Bern for an outstanding educational and learning experience for dermatologists and venereologists.

Immerse yourself in the latest research findings, science, and innovation.

Keynote Speakers

List of Speakers in alphabetical order

Keynote Speakers

Prof. Dr. Vincenzo Bettoli

09.11.2022, 14.00-14.25
Kursaal, Arena

The difficult acne patient

How to use spirinaloctone and isotreinoin

Università di Ferrara, Italy

Lecture Summary

Oral Isotreinoin is the most effective drug available, for more than 30 years, in the treatment of moderate-to-severe cases of acne. The recent data of the literature and the routine experience, collected over the last 3 decades have clearly demonstrated that isotretinoin, if correctly prescribed, is safe, effective and easy to manage. Spironolactone is a molecule with an antiandrogen potential. It is widely used, all over the world, in the treatment of female acne cases when the involvement of hormonal factors, like in PCOS, is relevant and OC can’t be assumed. Clinical effects and tolerability make spironolactone very useful in acne.

Prof. Dr. Andreas Wollenberg

09.11.2022, 14.25-14.50
Kursaal, Arena

Chronic prurigo

New therapeutic approach for your practice

University of Munich, Germany

Lecture Summary

Prof. Dr. Giuseppe Argenziano

09.11.2022, 14.50-15.15
Kursaal, Arena

Smart Medicine

The future is now: noninvasive, computer-assisted methods to diagnose melanoma in your practice

University of Campania, Naples Italy

Lecture Summary

We are beginning to move away from clinicopathologic diagnosis into an era of clinicoimaging diagnosis”. That is what June K. Robinson, the editor of Archives of Dermatology, wrote in February 2005. This vision is based on the fact that dermoscopy, among the other imaging techniques that have been developed in the last years, is changing the practice of diagnosing cutaneous disorders, in general, and skin cancer, in particular. The fact that about 6000 papers have been published in the field of dermoscopy in about 25 years is one of the strongest pieces of evidence proving that this vision is true and dermoscopy is rapidly becoming a standard of care in many countries all over the world.

Prof. Dr. Alexander J. Stratigos

09.11.2022, 15.45-16.10
Kursaal, Arena

State of the art in your practice 3

Dos and don'ts in the management of basal cell and squamous cell carcinomas: pitfalls and high risk patients in your practice

Athens, Greece President Eof ADV, National and Kapodistrian University of Athens Chair, 1st Department of Dermatology-Venereology Andreas Sygros Hospital for Skin and Venereal Diseases

Lecture Summary

Basal cell carcinoma (BCC) and squamous cell carcinoma (cSCC) comprise the most frequently diagnosed malignant tumors in humans. Although the majority of these tumors are managed effectively with curative surgery and/or radiation, in a subset of cases with advanced disease (locally advanced or with nodal/distant metastases), systemic therapy is often required. Novel treatments such as hedgehog inhibitors and anti-PD1 immunotherapy are now standard of care treatment for advanced keratinocyte carcinoma, yielding an improved efficacy and an acceptable safety profile. The current presentation aims to critically address the current therapeutic landscape of BCCs/cSCCs and discuss the yet controversial areas in management, such as patient selection, staging approaches, primary and secondary resistance and optimal use of the currently available therapeutic options in daily clinical practice.

Prof. Dr. Luca Borradori

09.11.2022, 16.20-16.35
Kursaal, Arena

State of the art in your practice 4

Autoimmune bullous dermatoses

Inselspital Bern, Director of the Clinic of Dermatology

Prof. Dr. Britta Maurer

09.11.2022, 16.35-17.00
Kursaal, Arena

Smart Medicine

When and which serological testing makes sense in connective-tissue disease workup?

Inselspital Bern, Universityclinic for Rheumatology, Bern

Prof. Dr. med. Michel GIlliet

10.11.2022, 14.00-14.25
Kursaal, Arena

Translational advances

Precision medicine in dermatology for your practice

Professor and Chairman of the Department of Dermatology, CHUV University Hospital Lausanne

Prof. Dr. med. Carle Paul

10.11.2022, 14.50-15.15
Kursaal, Arena

Controversy

Psoriasis management

Academic Dermatologist and Executive Coach Centre Hospitalier Universitaire de Toulouse, FR

Lecture Summary

Management of psoriasis has changed dramatically in the past 15 years.The current controversies in development in psoriasis treatment concern three areas. Firstly the respective role of physicians and patients in the decision-making process. A better integration of patient preferences in disease management is desirable. There is still a disconnect between patients and physicians concerning disease severity assessment and therapeutic objectives. Integrating a holistic patient centered view on disease management is warranted. Physician training to improve emotional intelligence competencies may be useful to better connect with patients. Secondly, the classical therapeutic strategy for moderate to severe psoriasis starting with phototherapy and classical systemic treatment is currently under scrutiny. Recent evidence suggests that early intervention with the newer biological agents in patients with new onset psoriasis may be most effective to achieve disease control. Whereas such strategy can also prevent the development of psoriatic arthritis in high-risk patients remains the be determined. It is also advisable to discuss if such strategies are sustainable from an economical standpoint. Thirdly the current therapeutic agents in late development should address the residual medical need in patients with moderate to severe psoriasis. The robust therapeutic armamentarium in psoriasis make the dream of sustained complete clearance of psoriasis true for the majority of patients. Something we could not imagine as possible at the end of the last century.

All Speakers

Dr. med. Michael Benzaquen

10.11.2022, 11.05-12.05
Panorama

Workshop 5

Palliative Therapy of squamous cell carcinomas

Inselspital Bern, Dermatologie

Prof. Dr. Ralph Braun

10.11.2022, 11.05-12.05
Panorama

Workshop 5

Dermoscopy of squamous cell carcinomas

Universitätsspital Zürich USZ

Lecture Summary

Dr. med. Christina Bürgler

10.11.2022, 10.00-11.00
Panorama

Workshop 2

VASCULAR ANOMALIES – WHEN IS IT NOT JUST A STAIN ON THE SKIN?

Inselspital Bern, Dermatologie


Prof. Dr. med. Curdin Conrad

11.11.2022, 12.15-12.45
Kursaal, Arena

Symposium 9

Targeting the Window of Opportunity in Inflammatory Skin Diseases

Professor of Dermatology at CHUV Lausanne University Hospital

Prof. Dr. med. Reinhard Dummer

11.11.2022, 14.20-14.40
Kursaal, Arena

What's new Sessions

Dermato-oncology

Professor at University Hospital Zürich

Lecture Summary

Cutaneous melanoma, cutaneous non-melanoma skin cancers including Merkel Cell Carcinoma today are paradigms for modern cancer therapy. Chemotherapy traditionally has modest impact on the survival in these cancer types. After decades of standstill, there is now a dramatic improvement of the outcome by the introduction of new medications. Today 5 antibodies targeting the PD1-PDL1 interaction are approved for skin cancers and 6 small molecules interfering with the MAPK-Kinase pathway in BRAF mutant melanomas. There are also early signs for the efficacy of MDM2 inhibitors. Additional innovations are based on new scheduling of these drugs in the neoadjuvant / adjuvant settings

Dr. med. Magali Dumont

10.11.2022, 15.45-16.45
Garten

Workshop 9

Corrective dermatology and Dermato-aesthetics : live-course and hands-on workshop

CHUV Lausanne University Hospital

Dr. Johanna Flordelis

10.11.2022, 15.45-16.45
Panorama

Workshop 7

Updates in dermatopathology for the clinician

Universitätsspital Zürich USZ

Lecture Summary

In this lecture we will focus on recent developments in dermatopathology, with an emphasis on publications within the last 2 years. We will talk about advances in immunohistochemistry and the implications of new molecular techniques especially in the field of difficult melanocytic neoplasms. We will present novelties in the classification of cutaneous lymphomas and new histopathological clues for the diagnosis of inflammatory skin conditions.

Alexander Fust

10.11.2022, 10.00-11.00
Garten

Workshop 3

PERSONNEL RECRUITMENT AND MANAGEMENT IN THE DERMATOLOGICAL PRACTICE: SPECIAL FEATURES IN DEALING WITH GENERATIONS Y,Z AND ALPHA

HSG

PD Dr. med. Olivier Gaide

10.11.2022, 10.00-11.00
Kursaal Arena

Workshop 1

CLINICAL DIVERSITY OF THE SCC, DIAGNOSTIC TOOLS AND CRITICAL RISK FACTORS

CHUV Lausanne

Prof. Dr. Emmanuella Guenova

10.11.2022, 15.45-16.45
Panorama

Workshop 7

When dermatology explains dermatopathology and dermatopathology explains dermatology

CHUV Lausanne University Hospital


PD Dr. Karin Hartmann

11.11.2022, 15.20-15.40
Kursaal Arena

What's new Sessions

Dermato-allergolgy

Universitätsspital Basel, USB

Lecture Summary

Dr. med. Sonja Haverkamp

10.11.2022, 10.00-11.00
Kursaal Arena

Workshop 1

SURGICAL MANAGEMENT OF DEMANDING SCC AND DISCUSSION ABOUT SENTINEL LYMPH NODE EXCISION

KSSG St. Gallen

Dr. med. Kristine Heidemeyer

11.11.2022, 15.40-16.00
Kursaal Arena

What's new Sessions

Lasers and energy based devices

Inselspital Bern, Dermatologie

Lecture Summary

Prof. Dr. med. Daniel Hohl

10.11.2022, 09.00-11:00
Kursaal, Arena

SSDV Assembly

President of the SSDV

Prof. Dr. med. Robert Hunger

10.11.2022, 14.25-14.50
Kursaal, Arena

Controversy

Dermato-oncology

Inselspital Bern Leitender Arzt Dermatologie

Dr. med. Stefanie Häfliger

10.11.2022, 10.00-11.00
Panorama

Workshop 2

SKIN AND BRAIN – WHEN TO SUSPECT A NEUROCUTANEOUS DISORDER?

Inselspital Bern, Dermatologie

PD Dr. Laurence Imhof

10.11.2022, 11.05-12.05
Kursaal Arena

Workshop 4

Update on the treatment of tattoos and their complications

Universitätsspital Zürich USZ

Lecture Summary

Prof. Dr. Yogeshvar N. Kalia

10.11.2022, 11.05-12.05
Kursaal Arena

Workshop 4

Laser assisted drug delivery, a basic science view

Université de Genève

Lecture Summary

Fractional laser ablation can increase the cutaneous bioavailability of poorly-delivered low molecular weight drugs. It also enables the targeted cutaneous administration of therapeutic macromolecules. In this talk, I will describe how experimental parameters that affect drug delivery kinetics can be used to increase bioavailability and thereby improve treatment efficacy.

More information

Dr. med. François Kuonen

10.11.2022, 11.05-12.05
Panorama

Workshop 5

Radiotherapy of squamous cell carcinomas

CHUV Lausanne University Hospital


PD Dr. Emmanue Laffitte

11.11.2022, 14.00-14.20
Kursaal Arena

What's new Sessions

Clinical dermatology

Hôpitaux Universitaires de Genève

Dr. med. Claudia Lang

09.11.2022, 17.50-18.20
Kursaal, Arena

Symposium 3

JAK Inhibitors Atopische Dermatitis

Inselspital Bern, Dermatologie

PD Dr. Severin Läuchli

11.11.2022, 14.40-15.00
Kursaal Arena

What's new Sessions

Dermato-surgery

Universitätsspital Zürich USZ

Lecture Summary

This lecture will highlight the most important advances in dermatologic surgery during the last two years. Topics that will be covered will address indications and practical aspects of Mohs micrographic surgery, practical tips for surgical reconstructions and important points to consider during the perioperative period such as patient anxiety, preoperative antibiotics and anticoagulation.

PD Dr. med. Cristina Mangas de Arriba

10.11.2022, 10.00-11.00
Kursaal Arena

Workshop 1

ONCOLOGICAL EMERGENCY PLAN FOR ADVANCED SCC; PROSPECT OF A PLAN B?

EOC, Ospedale Regionale Bellinzona e Valli

Lecture Summary

Dr. med. Martin Metz

09.11.2022, 17.15-17.45
Kursaal, Arena

Symposium 2

Never Ending Itch – Addressing Clinical Challenges in Prurigo Nodularis

tbd

Bettina Mutter

10.11.2022, 16.00-17:00
Kursaal, Arena

Podium Politics

Founder, owner Mutter & Partner Consulting

Lecture Summary

Bettina Mutter is a proven strategy consultant and public affairs specialist with many years of experience and an extensive network of contacts in business, politics and culture.

More information

PD Dr. Beda Mühleisen

10.11.2022, 15.45-16.45
Panorama

Workshop 7

Dermatopathology: Red flags and pitfalls important in your practice

Universitätsspital Basel, USB

Lecture Summary


Prof. Dr. med. Alexander Navarini

09.11.2022, 13.00-13.30
Kursaal, Arena

Symposium 1

Targeting the Window of Opportunity in Inflammatory Skin Diseases

Professor of Dermatology at USB University Hospital Basel

Prof. Dr. med. Tobias Plaza

11.11.2022, 11.05-12.05
Garten

Workshop 6

QUALITY MANAGEMENT IN DERMATOLOGICAL GROUP PRACTICE: SENSE AND NONSENSE IN PRACTICAL IMPLEMENTATION

Plaza Kliniken

Dr. med. Martin Theiler Pang

10.11.2022, 10.00-11.00
Panorama

Workshop 2

SKIN AND BRAIN – WHEN TO SUSPECT A NEUROCUTANEOUS DISORDER?

Universitätskinderspital Zürich

Dr. med. Roberta Vasconcelos Berg

10.11.2022, 11.05-12.05
Kursaal Arena

Workshop 4

News Laser und Energy Based Devices (EBD)

USB University Hospital Basel

Lecture Summary

Prof. Dr. med. Nikhil Yawalkhar

10.11.2022, 12.05-12.35
Kursaal, Arena

Symposium 4

PSORIASIS EARLY INTERVENTION WITH BIOLOGICS IN PSO AND PSA

Inselspital Bern, Leitender Arzt Dermatologie